Abstract
Toxoplasma gondii (T. gondii) is the most common cause of secondary central nervous system infection in immunocompromised persons such as AIDS patients. Dihydrofolate reductase and thymidylate synthase enzymes have been studied as attractive targets against parasitic diseases, since they are involved in cell proliferation and influence on DNA synthesis. In this paper, we propose three-dimensional structures of T. gondii dihydrofolate reductase and thymidylate synthase based on homology modeling. In addition, we assessed the interaction mode of pyrimidine analogs in the active site of T. gondii and human enzymes, in order to direct the planning of new compounds that can be used against toxoplasmosis. According to the docking studies, predicted pIC50 values for proposed compounds were higher than those of the experimentally most active compound.
Keywords: Molecular modeling, toxoplasmosis, dihydrofolate reductase and thymidylate synthase.
Current Bioactive Compounds
Title:Interactions of Pyrimidine Derivatives with Dihydrofolate Reductase and Thymidylate Synthase: Directions Toward Combating toxoplasmosis
Volume: 9 Issue: 2
Author(s): Letícia C. Assis, Letícia Santos-Garcia, Teodorico C. Ramalho and Elaine F. F. da Cunha
Affiliation:
Keywords: Molecular modeling, toxoplasmosis, dihydrofolate reductase and thymidylate synthase.
Abstract: Toxoplasma gondii (T. gondii) is the most common cause of secondary central nervous system infection in immunocompromised persons such as AIDS patients. Dihydrofolate reductase and thymidylate synthase enzymes have been studied as attractive targets against parasitic diseases, since they are involved in cell proliferation and influence on DNA synthesis. In this paper, we propose three-dimensional structures of T. gondii dihydrofolate reductase and thymidylate synthase based on homology modeling. In addition, we assessed the interaction mode of pyrimidine analogs in the active site of T. gondii and human enzymes, in order to direct the planning of new compounds that can be used against toxoplasmosis. According to the docking studies, predicted pIC50 values for proposed compounds were higher than those of the experimentally most active compound.
Export Options
About this article
Cite this article as:
Assis C. Letícia, Santos-Garcia Letícia, Ramalho C. Teodorico and Cunha F. F. da Elaine, Interactions of Pyrimidine Derivatives with Dihydrofolate Reductase and Thymidylate Synthase: Directions Toward Combating toxoplasmosis, Current Bioactive Compounds 2013; 9 (2) . https://dx.doi.org/10.2174/22115528112019990010
DOI https://dx.doi.org/10.2174/22115528112019990010 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target
Current Signal Transduction Therapy Advances in Helper-Dependent Adenoviral Vector Research
Current Gene Therapy Innate Immunity in Alzheimer’s Disease: A Complex Affair
CNS & Neurological Disorders - Drug Targets Chitosan Formulations as Carriers for Therapeutic Proteins
Current Drug Discovery Technologies The Role of Hypocarbia in the Development of Cystic Periventricular Leukomalacia
Current Pediatric Reviews Chronic Stress Impacts on Olfactory System
CNS & Neurological Disorders - Drug Targets Current Concepts in the Management of Diabetic Polyneuropathy
Current Diabetes Reviews Gene Therapy Approaches for the Selective Killing of Cancer Cells
Current Pharmaceutical Design Link between Metabolic Syndrome and Insulin Resistance
Current Vascular Pharmacology Retroviral Vector-mediated Gene Therapy for Metabolic Diseases: An Update
Current Pharmaceutical Design Small Molecule Inhibitors of Peptidylprolyl cis/trans Isomerase
Current Enzyme Inhibition Targeting Protein Degradation in the Nervous System
Current Medicinal Chemistry - Central Nervous System Agents The Endocannabinoid/Endovanilloid System and Depression
Current Neuropharmacology SGLT-2 Inhibition: Novel Therapeutics for Reno-and Cardioprotection in Diabetes Mellitus
Current Diabetes Reviews Melatonin and Its Therapeutic Potential in Neuroprotection
Central Nervous System Agents in Medicinal Chemistry Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers
Current Pharmaceutical Design The Relationship Between HIV Infection and Cardiovascular Disease
Current Cardiology Reviews Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis
Recent Patents on Biomedical Engineering (Discontinued) Treasures Hunt in Old Mines: Terminalia chebula-Based Traditional Herbal Medicinal Products
The Natural Products Journal Antioxidants Countermeasures Against Sulfur Mustard
Mini-Reviews in Medicinal Chemistry